MDLZ Mondelez International
Intrinsic value$11.93
Price (at call)$62.43
Margin of safety
-80.9%
vs market (rating basis)
-49.5%
Model unavailable; showing baseline valuation.
⚠ LLM error: empty response; using baseline
The story
Value drivers
| Revenue growth (Y1) | 7.0% |
| Terminal growth | 3.5% |
| Forecast horizon | 10y |
| Target operating margin | 9.8% |
| Years to target margin | 5 |
| Sales-to-capital | 0.84 |
| Beta | 0.50 |
| Failure probability | 0.0% |
| Cost of capital (WACC) | 6.8% |
| Terminal WACC | 8.6% |
Valuation bridge
| PV of explicit FCFF | 4.75B |
| PV of terminal value | 29.70B |
| Equity value | 15.31B |
| ÷ shares → per share | $11.93 |
News
score · 8 articles
- Why Is Mondelez (MDLZ) Down 3.1% Since Last Earnings Report?
- Mondelez International (MDLZ) Enters The US Protein Bar Market
- 1 Unpopular Stock That Deserves a Second Chance and 2 We Question
- How Oreo’s endless flavor innovations help keep it on top
- 2 Dividend Stocks to Buy and Hold for Long-Term Safety and Income
- Kraft Heinz Q2 Earnings Beat as 2026 Organic Sales Outlook Improves
- Is Kraft Heinz Stock a Buy as Low Valuation Meets Execution Risk?
- Mondelēz brings UK protein bar Grenade to the US
Projected free cash flow to the firm
| Yr | Revenue | Growth | Margin | NOPAT | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | 42.04B | 7.0% | 9.8% | 3.05B | 3.27B | -219.98M | -205.98M |
| 2 | 44.80B | 6.6% | 9.8% | 3.25B | 3.31B | -53.76M | -47.14M |
| 3 | 47.57B | 6.2% | 9.8% | 3.45B | 3.32B | 136.15M | 111.78M |
| 4 | 50.34B | 5.8% | 9.8% | 3.66B | 3.31B | 350.00M | 269.06M |
| 5 | 53.06B | 5.4% | 9.8% | 3.85B | 3.27B | 587.66M | 423.02M |
| 6 | 55.74B | 5.0% | 9.8% | 4.05B | 3.20B | 848.64M | 572.01M |
| 7 | 58.33B | 4.7% | 9.8% | 4.24B | 3.10B | 1.13B | 714.47M |
| 8 | 60.82B | 4.3% | 9.8% | 4.42B | 2.98B | 1.44B | 848.98M |
| 9 | 63.18B | 3.9% | 9.8% | 4.59B | 2.83B | 1.76B | 974.20M |
| 10 | 65.39B | 3.5% | 9.8% | 4.75B | 2.65B | 2.10B | 1.09B |
⚠ Extreme gap to market price — large, heavily-covered stocks are rarely mispriced this much; the gap likely embeds disruption, decline, or balance-sheet risk the model underweights. Treat as a flag to investigate, not a verdict.